462 related articles for article (PubMed ID: 33358490)
1. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
[TBL] [Abstract][Full Text] [Related]
2. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
[TBL] [Abstract][Full Text] [Related]
3. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Cucchiara V; Tian Z; Shariat SF; Saad F; Longo N; Montorsi F; Briganti A; Mirone V; Karakiewicz PI
Eur Urol Oncol; 2021 Oct; 4(5):792-801. PubMed ID: 33293235
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
[TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study.
Ślusarczyk A; Zapała P; Zapała Ł; Rajwa P; Moschini M; Laukhtina E; Radziszewski P
Urol Oncol; 2024 Jan; 42(1):22.e1-22.e11. PubMed ID: 37981503
[TBL] [Abstract][Full Text] [Related]
8. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
[TBL] [Abstract][Full Text] [Related]
9. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
[TBL] [Abstract][Full Text] [Related]
10. Survival impact of variant histology in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Ye J; Wang X; Liao X; Chen Z; Wang X; Zhang C; Han P; Wei Q; Bao Y
Urol Oncol; 2024 Mar; 42(3):69.e1-69.e9. PubMed ID: 38151426
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
[TBL] [Abstract][Full Text] [Related]
12. Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy.
Zamboni S; Foerster B; Abufaraj M; Seisen T; Roupret M; Colin P; De la Taille A; Di Bona C; Peyronnet B; Bensalah K; Herout R; Wirth MP; Novotny V; Soria F; Chlosta P; Antonelli A; Simeone C; Baumeister P; Mattei A; Montorsi F; Simone G; Gallucci M; Matsumoto K; Karakiewicz PI; Briganti A; Xylinas E; Shariat SF; Moschini M; ;
BJU Int; 2019 Nov; 124(5):738-745. PubMed ID: 30908835
[TBL] [Abstract][Full Text] [Related]
13. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
14. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
15. The long-term outcome of nephron-sparing surgery versus radical nephroureterectomy for organ-localized upper urinary tract urothelial carcinoma: a population-based study of 1969 patients.
Qiu J; Deng R; Yu C; Gong K
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14869-14878. PubMed ID: 37598342
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
18. The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy.
Huang LH; Chen CS; Li JR; Chiu KY; Wang SS; Yang CK; Cheng CL; Lin CC; Ou YC
BMC Cancer; 2024 Feb; 24(1):247. PubMed ID: 38388388
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of renal function for upper tract urothelial carcinoma who underwent radical nephroureterectomy: Sex differences.
Chien TM; Li CC; Lu YM; Chang HW; Chou YH; Wu WJ
J Formos Med Assoc; 2022 Nov; 121(11):2182-2190. PubMed ID: 35370029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]